Gland Pharma Share Price

Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.As of 26 May 2026, Gland Pharma share price is ₹2,307.90. The stock opened at ₹2,339.70, compared to its previous close of ₹2,333.80. During today's trading session, Gland Pharma share price moved in the range of ₹2,252.10 to ₹2,354.70, with an average price of ₹2,303.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,252.10 and a high of ₹2,354.70.

The market capitalization of Gland Pharma is ₹38,429 Crs, with a P/E ratio of 37.4 and a dividend yield of 0.86%.